Saltar al contenido
Merck

Ceftriaxone-induced hemolytic anemia: case report and review of literature.

Journal of pediatric hematology/oncology (2014-06-01)
Michael S Northrop, Hemant S Agarwal
RESUMEN

Ceftriaxone is a frequently used empiric antibiotic in children. Acute hemolysis is a rare side effect of ceftriaxone therapy associated with a high mortality rate. A 14-year-old boy suffering from Crohn disease developed bacterial pneumonia that was treated with ceftriaxone. We report successful management of ceftriaxone-induced hemolytic anemia (CIHA) in this patient and review the CIHA literature in pediatric patients. Early recognition of CIHA with prompt discontinuation of ceftriaxone therapy may have a beneficial role in reduction of high mortality seen in these patients.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ceftriaxone disodium salt hemi(heptahydrate), third-generation cephalosporin antibiotic
Número de referencia del producto (SKU)
Tamaño de envase
Disponibilidad
Precio
Cantidad
USP
Ceftriaxone sodium, United States Pharmacopeia (USP) Reference Standard
Número de referencia del producto (SKU)
Tamaño de envase
Disponibilidad
Precio
Cantidad
Supelco
Ceftriaxone Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
Número de referencia del producto (SKU)
Tamaño de envase
Disponibilidad
Precio
Cantidad
Ceftriaxone sodium, European Pharmacopoeia (EP) Reference Standard
Número de referencia del producto (SKU)
Tamaño de envase
Disponibilidad
Precio
Cantidad